Jiangsu Zhongbang Pharmaceutical Co Ltd | CAS 139481-58-6 | Related Intermediates | Manufacturers & Suppliers

CAS 139481-58-6

Chemistry, 2 End Use API, 45 Related Intermediates

Manufacturers/Suppliers

2 Suppliers

2 Suppliers

Also known as: Candesartan ethyl ester, 139481-58-6, Ethyl 1-((2'-(2h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate, 8tt2y1f36j, Ethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate, Ethyl 1-((2'-(1h -tetrazol-5-yl)biphenyl-4-yl)methyl(-2-ethoxybenzimidazole-7-carboxylate

Molecular Formula

C₂₆H₂₄N₆O₃

Molecular Weight

468.5 g/mol

InChI Key

BCPWNYREAURMOP-UHFFFAOYSA-N

FDA UNII

8TT2Y1F36J

1 2D Structure

CAS 139481-58-6

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate

2.1.2 InChI

InChI=1S/C26H24N6O3/c1-3-34-25(33)21-10-7-11-22-23(21)32(26(27-22)35-4-2)16-17-12-14-18(15-13-17)19-8-5-6-9-20(19)24-28-30-31-29-24/h5-15H,3-4,16H2,1-2H3,(H,28,29,30,31)

2.1.3 InChI Key

BCPWNYREAURMOP-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OCC

2.2 Other Identifiers

2.2.1 UNII

8TT2Y1F36J

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Candesartan Ethyl Ester

2. 139481-58-6

3. Ethyl 1-((2'-(2h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate

4. 8tt2y1f36j

5. Ethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate

6. Ethyl 1-((2'-(1h -tetrazol-5-yl)biphenyl-4-yl)methyl(-2-ethoxybenzimidazole-7-carboxylate

7. Ethyl 2-ethoxy-1-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)-1h-benzimidazole-7-carboxylate

8. 1h-benzimidazole-7-carboxylic Acid, 2-ethoxy-1-((2'-(1h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Ethyl Ester

9. 1h-benzimidazole-7-carboxylic Acid, 2-ethoxy-1-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Ethyl Ester

10. Ethyl 2-ethoxy-1-[[(2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl]benzimidazole]-7-carboxylate

11. Unii-8tt2y1f36j

12. Ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl]-1h-benzimidazole-7-carboxylate

13. Candesartan Cilexetil Ep Impurity A

14. Candesartan Cilexetil Impurity A [ep]

15. Ec 642-256-1

16. Candesartan Cilexetil Specified Impurity A [ep]

17. Schembl683298

18. Dtxsid50161059

19. Zinc603603

20. Amy22169

21. Bcp07078

22. Ethyl -2-ethoxy-1-[[(2-(1htetrazol-5-yl)biphenyl-4-yl-) Methyl]

23. Akos015964210

24. Candesartan Cilexetil Related Compound A

25. Ac-18527

26. As-58069

27. Ethyl -2-ethoxy-1-[[(2 Inverted Exclamation Marka-(1htetrazol-5-yl)biphenyl-4-yl-) Methyl]benzimidazole]-7-carboxylate

28. Ethyl 1-((2'-(1h-tetrazol-5-yl)-(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-1h-benzo(d)imidazole-7-carboxylate

29. Ft-0664224

30. D95996

31. 481e699

32. L006258

33. A1-01748

34. J-007280

35. Candesartan Cilexetil Impurity A [ep Impurity]

36. Q27270999

37. Ethyl-2-ethoxy-1-[[(2-(1htetrazol-5-yl)biphenyl-4-yl-)methyl]

38. Ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl) Biphenyl-4-yl]methyl]benzimidazole-7-carboxylate

39. Ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylate

40. Ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]-methyl]benzimidazole-7-carboxylate

41. Ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl]-benzimidazole-7-carboxylate

42. Ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazoie-7-carboxylate

43. Ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate

44. Ethyl 2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate

45. Ethyl 2-ethoxy-l-[[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]-methyl]benzimidazole-7-carboxylate

46. Ethyl 2-ethoxy-l-[[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate

47. (ethyl 1-{[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl-2-ethoxybenzimidazole-7-carboxylate)

48. Ethyl 2-ethoxy-1-[[2'-(1 H-tetrazol-5-yl)biphenyl-4-yl]-methyl]benzimidazole-7-carboxylate

49. Ethyl 2-ethoxy-1-[[2'-(1 H-tetrazol-5-yl)biphenyl-4-yl]methyl]-benzimidazole-7-carboxylate

50. Ethyl 2-ethoxy-1-{[2'-(1h-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1h-1,3-benzodiazole-7-carboxylate

51. Ethyl1-((2'-(2h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₂₄N₆O₃
Molecular Weight	468.5 g/mol
XLogP3	4.8
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	9
Exact Mass	468.19098865 g/mol
Monoisotopic Mass	468.19098865 g/mol
Topological Polar Surface Area	108 Å²
Heavy Atom Count	35
Formal Charge	0
Complexity	690
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Jiangsu Zhongbang Pharmaceutical Co...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

2-Ethoxy-1-[[2

PDF Supplier PDF

URL Supplier Web Content

CAS Number

1397836-41-7

End Use API

Azilsartan

About the Company

Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...

Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.

ASK
US